KRT19 and hepatocellular carcinoma: In addition, considering the chemo-resistant nature of progenitor cells[51] and unfavorable improvement of adjuvant TACE in HCC with a high progenitor cell profile,[49] other adjuvant treatment strategies that outperformed adjuvant TACE are eagerly participated for CK7/CK19 double positive HCC.